Amgen

RNAi Is On Sale
Motley Fool
Tue, 11/30/10 - 10:52 am
RNAi
Merck
Alnylam
Pfizer
Amgen
Novartis
Eli Lilly
Roche
Biotech Calendar: Key Dates for December
TheStreet.com
Tue, 11/30/10 - 09:20 am
Delcath
Arena Pharmaceuticals
RXi Pharmaceuticals
Cell Therapeutics
Amgen
Incyte
Celgene
Corcept Therapeutics
Affymax
Targacept
Exelixis
Orexigen
ONYX Pharmaceuticals
Seattle Genetics
MannKind
Alimera
AstraZeneca
Human Genome Sciences
Actelion Takeover: Constant Speculation, Doubts Linger
Seeking Alpha
Mon, 11/29/10 - 09:04 am
M&A
Abbott Laboratories
Actelion
GSK
JNJ
Roche
Amgen
Bristol-Myers Squibb
Amgen Holder Invesco Says Potential Actelion Deal Not `Hugely Compelling'
Bloomberg
Tue, 11/23/10 - 10:49 am
Amgen
M&A
Actelion
Biotech's Biggest R&D Spenders 2010
Fierce Biotech
Mon, 11/22/10 - 10:45 am
biotech
R&D
Amgen
Biogen Idec
Gilead Sciences
Genzyme
Celgene
Kyowa Hakko Kirin
Vertex Pharmaceuticals
Life Technologies
CSL
Amylin
Genmab
Cubist Pharmaceuticals
MannKind
companies
Merial
Actelion: Genzyme-Sanofi Redux?
WSJ Online
Mon, 11/22/10 - 10:32 am
Genzyme
Actelion
Sanofi
M&A
Bayer
Amgen
AstraZeneca
One Drug, Two Names, Two Wildly Different Prospects
Motley Fool
Sat, 11/20/10 - 12:22 pm
Amgen
Prolia
Xgeva
denosumab
Exclusive Picks From Street’s Top Biotech Analyst
CNBC
Sat, 11/20/10 - 12:15 pm
Human Genome Sciences
Amgen
United Therapeutics
Amgen's Bone Drug Denosumab Cleared to Treat Fractures in Cancer Patients
Bloomberg
Sat, 11/20/10 - 12:10 pm
Amgen
denosumab
cancer
Amgen's Xgeva Approved
Yahoo/Zacks.com
Fri, 11/19/10 - 11:16 am
FDA
Amgen
Xgeva
Actelion, Eyed by Amgen, May Fetch $9.8 Billion in Takeover, Analysts Say
Bloomberg
Thu, 11/18/10 - 07:58 am
Actelion
Amgen
M&A
Actelion shares surge (again) as M&A buzz hits fever pitch
Fierce Biotech
Wed, 11/17/10 - 11:46 am
Actelion
M&A
Amgen
Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
Bradenton Herald, FL
Sat, 11/6/10 - 01:25 pm
Prolia
osteoporosis
Amgen
[video]Amgen in Focus
Yahoo/CNBC
Wed, 11/3/10 - 07:00 pm
Kevin Sharer
Amgen
Pharma CEOs
healthcare reform
Time to Sell Amgen?
Motley Fool
Wed, 11/3/10 - 06:57 am
Amgen
Amgen proposes key hurdles for biosimilar regs
Fierce Biotech
Tue, 11/2/10 - 11:27 am
Amgen
biosimilars
Biotech Calendar: Key Dates for November
TheStreet.com
Fri, 10/29/10 - 12:11 pm
biotech
Merck
Gilead Sciences
Indenix
Pharmasset
Bristol-Myers Squibb
Dendreon
Cadence Pharmaceuticals
Vical
MELA Sciences
Human Genome Sciences
Amgen
Amgen's Bone Drug Prolia Gets Final Approval From U.K. Health-Cost Agency
Bloomberg
Wed, 10/27/10 - 11:50 am
Amgen
Prolia
UK
NHS
Thank Goodness for Amgen's New Kids
Motley Fool
Tue, 10/26/10 - 03:20 pm
Amgen
Prolia
Amgen Case Shows How to Hide Bad Drug Data and Get Away With It
BNET Pharma
Mon, 10/25/10 - 08:14 pm
Amgen
Epogen
Aranesp
anemia

Pages